GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » Cyclically Adjusted PS Ratio

ALBT (Avalon Globocare) Cyclically Adjusted PS Ratio : 1.28 (As of May. 13, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare Cyclically Adjusted PS Ratio?

As of today (2025-05-13), Avalon Globocare's current share price is $3.75. Avalon Globocare's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was $2.92. Avalon Globocare's Cyclically Adjusted PS Ratio for today is 1.28.

The historical rank and industry rank for Avalon Globocare's Cyclically Adjusted PS Ratio or its related term are showing as below:

ALBT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.84   Med: 1.5   Max: 2.65
Current: 1.33

During the past years, Avalon Globocare's highest Cyclically Adjusted PS Ratio was 2.65. The lowest was 0.84. And the median was 1.50.

ALBT's Cyclically Adjusted PS Ratio is ranked better than
59.72% of 1291 companies
in the Real Estate industry
Industry Median: 1.87 vs ALBT: 1.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Avalon Globocare's adjusted revenue per share data for the three months ended in Dec. 2024 was $0.259. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $2.92 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Avalon Globocare Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Avalon Globocare's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare Cyclically Adjusted PS Ratio Chart

Avalon Globocare Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2.40 1.12

Avalon Globocare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.40 1.58 2.35 1.05 1.12

Competitive Comparison of Avalon Globocare's Cyclically Adjusted PS Ratio

For the Real Estate Services subindustry, Avalon Globocare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's Cyclically Adjusted PS Ratio Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's Cyclically Adjusted PS Ratio falls into.


;
;

Avalon Globocare Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Avalon Globocare's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3.75/2.92
=1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avalon Globocare's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 is calculated as:

For example, Avalon Globocare's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.259/133.1571*133.1571
=0.259

Current CPI (Dec. 2024) = 133.1571.

Avalon Globocare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.982 101.861 1.284
201612 0.797 101.863 1.042
201703 0.158 102.862 0.205
201706 0.870 103.349 1.121
201709 0.735 104.136 0.940
201712 0.701 104.011 0.897
201803 0.662 105.290 0.837
201806 1.033 106.317 1.294
201809 0.855 106.507 1.069
201812 0.707 105.998 0.888
201903 0.578 107.251 0.718
201906 0.798 108.070 0.983
201909 0.760 108.329 0.934
201912 0.947 108.420 1.163
202003 0.581 108.902 0.710
202006 0.572 108.767 0.700
202009 0.605 109.815 0.734
202012 0.835 109.897 1.012
202103 0.522 111.754 0.622
202106 0.496 114.631 0.576
202109 0.856 115.734 0.985
202112 0.581 117.630 0.658
202203 0.505 121.301 0.554
202206 0.491 125.017 0.523
202209 0.490 125.227 0.521
202212 0.451 125.222 0.480
202303 0.443 127.348 0.463
202306 0.449 128.729 0.464
202309 0.460 129.860 0.472
202312 0.438 129.419 0.451
202403 0.429 131.776 0.433
202406 0.439 132.554 0.441
202409 0.373 133.029 0.373
202412 0.259 133.157 0.259

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Avalon Globocare  (NAS:ALBT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Avalon Globocare Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Executives
Lourdes Felix director 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin director 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu director, 10 percent owner C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders director 431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu director 14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii director 1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy director 611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola officer: Chief Financial Officer 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin director, officer: CEO and President C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li director C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li director, officer: Chief Operating Officer C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel director 33 ALPINE DRIVE, MORGANVILLE NJ 07751